Tuberculosis control and elimination 2010-50: cure, care, and social development
- PMID: 20488524
- DOI: 10.1016/S0140-6736(10)60483-7
Tuberculosis control and elimination 2010-50: cure, care, and social development
Abstract
Rapid expansion of the standardised approach to tuberculosis diagnosis and treatment that is recommended by WHO allowed more than 36 million people to be cured between 1995 and 2008, averting up to 6 million deaths. Yet tuberculosis remains a severe global public health threat. There are more than 9 million new cases every year worldwide, and the incidence rate is falling at less than 1% per year. Although the overall target related to the Millennium Development Goals of halting and beginning to reverse the epidemic might have already been reached in 2004, the more important long-term elimination target set for 2050 will not be met with present strategies and instruments. Several key challenges persist. Many vulnerable people do not have access to affordable services of sufficient quality. Technologies for diagnosis, treatment, and prevention are old and inadequate. Multidrug-resistant tuberculosis is a serious threat in many settings. HIV/AIDS continues to fuel the tuberculosis epidemic, especially in Africa. Furthermore, other risk factors and underlying social determinants help to maintain tuberculosis in the community. Acceleration of the decline towards elimination of this disease will need invigorated actions in four broad areas: continued scale-up of early diagnosis and proper treatment for all forms of tuberculosis in line with the Stop TB Strategy; development and enforcement of bold health-system policies; establishment of links with the broader development agenda; and promotion and intensification of research towards innovations.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
The changing face of tuberculosis.Annu Rev Med. 1995;46:47-55. doi: 10.1146/annurev.med.46.1.47. Annu Rev Med. 1995. PMID: 7598480 Review.
-
Tuberculosis: a survey and review of current literature.Curr Opin Pulm Med. 1995 May;1(3):234-42. Curr Opin Pulm Med. 1995. PMID: 9363058 Review.
-
[Fight against tuberculosis in the world].Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):181-7. doi: 10.1016/j.pneumo.2014.03.004. Epub 2014 May 28. Rev Pneumol Clin. 2015. PMID: 24878188 Review. French.
-
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.Lancet Infect Dis. 2006 Aug;6(8):483-95. doi: 10.1016/S1473-3099(06)70549-7. Lancet Infect Dis. 2006. PMID: 16870527 Review.
-
Global Tuberculosis Control: Toward the 2015 Targets and Beyond.Ann Intern Med. 2015 Jul 7;163(1):52-8. doi: 10.7326/M14-2210. Ann Intern Med. 2015. PMID: 25915859
Cited by
-
Mycobacterium marinum SecA2 promotes stable granulomas and induces tumor necrosis factor alpha in vivo.Infect Immun. 2012 Oct;80(10):3512-20. doi: 10.1128/IAI.00686-12. Epub 2012 Jul 30. Infect Immun. 2012. PMID: 22851747 Free PMC article.
-
Total synthesis and biological evaluation of transvalencin Z.J Nat Prod. 2012 Jun 22;75(6):1037-43. doi: 10.1021/np200972s. Epub 2012 May 22. J Nat Prod. 2012. PMID: 22616579 Free PMC article.
-
A RARE PRESENTATION OF GENITOURINARY TUBERCULOSIS MIMICKING ABDOMINAL TUMOR.Acta Clin Croat. 2022 Mar;61(1):153-156. doi: 10.20471/acc.2022.61.01.20. Acta Clin Croat. 2022. PMID: 36398074 Free PMC article.
-
Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach.PLoS One. 2024 Jul 16;19(7):e0305855. doi: 10.1371/journal.pone.0305855. eCollection 2024. PLoS One. 2024. PMID: 39012889 Free PMC article.
-
Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.BMC Med. 2015 Apr 21;13:88. doi: 10.1186/s12916-015-0341-4. BMC Med. 2015. PMID: 25896465 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous